COMMUNIQUÉS West-GlobeNewswire

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1
08/06/2026
CRPS-RISE designed to support FDA regulatory submission for potential approval of neridronate in patients with CRPS-1 FDA has previously granted neridronate with Breakthrough Therapy, Fast Track, and Orphan Drug [...]
Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada
08/06/2026
HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les vétéranes et présente [...]
Capricor Therapeutics to Present at Upcoming Investor Conferences
08/06/2026
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that senior [...]
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
08/06/2026
Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing Intravacc offers state-of-the-art analytical methods for identity, content, [...]
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
08/06/2026
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq [...]
Healthcare Financial Management Association recognizes Dennis Dahlen for contributions to healthcare
08/06/2026
NATIONAL HARBOR, Md., June 08, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) presented its highest achievement award, the Richard L. Clarke Board of Directors Award, to Mayo Clinic CFO [...]
Healthcare Financial Management Association (HFMA) announces Matthew E. Cox as National Chair along with new officers, board members
08/06/2026
NATIONAL HARBOR, Md., June 08, 2026 (GLOBE NEWSWIRE) -- Matthew E. Cox officially assumed the role of National Chair of the Healthcare Financial Management Association (HFMA) during an induction ceremony at the [...]
Koi Peptides Expands Research Catalog In June 2026
08/06/2026
Wyoming, WY, June 08, 2026 (GLOBE NEWSWIRE) -- Research peptide reference standards in the Koi Peptides laboratory catalog have broadened with the addition of new reference compounds for in vitro analytical use. Each [...]
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial
08/06/2026
Raanana, Israel, June 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
08/06/2026
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies [...]
Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026
08/06/2026
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
Sharecare to honor extraordinary nurses through The DAISY Foundation’s global recognition program
08/06/2026
Nurses at Sharecare now eligible to be nominated for The DAISY Award for Extraordinary Nurses® by patients, their families, and colleagues, with honorees selected twice per year ATLANTA, June 08, 2026 (GLOBE NEWSWIRE [...]
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
08/06/2026
First regulatory approval for Sjögren’s disease (SjD) First and only approved therapy for SjD in China Approval based on positive Phase 3 results generated by collaborator RemeGen demonstrating statistically significant [...]
New Task Force to Develop Roadmap for Dementia Care Coordination in Ontario
08/06/2026
TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario (ASO) and the Brainwell Institute are pleased to announce the launch of a new task force to accelerate the transformation of dementia care [...]
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
08/06/2026
NORTHSTAR will evaluate the efficacy and safety of investigational oral gildeuretinol, designed to reduce the formation of toxic vitamin A dimers, a proven mechanism of Stargardt disease. The study will assess [...]
TOMI Environmental Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets
08/06/2026
New Drone, Robotics and AI-Enabled Deployment Initiatives Could Expand SteraMist Applications Across Robo-Taxis, Critical Infrastructure, Agriculture, Transportation and Public Health as Ebola, Hantavirus, Norovirus and [...]
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
08/06/2026
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to address chronic pain among women and women Veterans, outlining a roadmap for a pan- [...]
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
08/06/2026
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that Phase 1/2 clinical data for [...]
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
08/06/2026
Company remains on track for a planned December 2026 evaluation of the clinical trial’s primary endpoint OCALA, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) [...]

Pages